Venous Thromboembolism
No increased risk of heart attacks in users of HRTIt's not what you take but the way that you take it that can produce different results in women who take hormone replacement therapy (HRT), according to new research on the association between HRT and heart attacks, published online in Europe's leading cardiology journal, the European Heart Journal.
Migraine linked to blood clots in veins, venous thrombosisPeople with migraines may also be more likely to develop blood clots in their veins, and are more likely to have strokes and other cardiovascular problems, revealed by researchers.
Oral HRT doubles risk of blood clotsHormone replacement therapy (HRT) given in skin patches may cause fewer blood clots than HRT given orally, revealed by researchers in British Medical Journal, UK. Women who take the oral form of HRT more than double their risk of developing a blood clot.
Anemia drugs for cancer patients raises blood clots riskTreating anemia with a class of drugs known as erythropoiesis-stimulating agents (ESAs) is associated with an increased risk of venous thromboembolism (blood clots in the deep veins of the legs or in the lungs) and death among patients with cancer, according to an article in the February 27 issue of JAMA.
Ortho Evra contraceptive transdermal birth control patch label updateThe U.S. Food and Drug Administration (FDA) approved additional changes to the Ortho Evra Contraceptive Transdermal (Skin) Patch label to include the results of a new epidemiology study that found that users of the birth control patch were at higher risk of developing serious blood clots, also known as venous thromboembolism (VTE), than women using birth control pills. VTE can lead to pulmonary embolism.